文献
J-GLOBAL ID:202002253693600380
整理番号:20A2020315
阻害剤による重症血友病A患者におけるエミズマブに対する中和抗薬物抗体:詳細な実験室評価の新しい症例【JST・京大機械翻訳】
Neutralizing antidrug antibody to emicizumab in a patient with severe hemophilia A with inhibitors: New case with detailed laboratory evaluation
著者 (6件):
Harkins Druzgal Colleen
(Division of Hematology-Oncology, Department of Pediatrics, University of Virginia Health System, Charlottesville, VA, USA)
,
Kizilocak Hande
(Hemostasis and Thrombosis Center, Children’s Hospital Los Angeles, Los Angeles, CA, USA)
,
Brown Joshua
(Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, CA, USA)
,
Sennett Margaret
(Division of Hematology-Oncology, Department of Pediatrics, University of Virginia Health System, Charlottesville, VA, USA)
,
Young Guy
(Division of Hematology-Oncology, Department of Pediatrics, University of Virginia Health System, Charlottesville, VA, USA)
,
Young Guy
(Keck School of Medicine, University of Southern California, Los Angeles, CA, USA)
資料名:
Journal of Thrombosis and Haemostasis
(Journal of Thrombosis and Haemostasis)
巻:
18
号:
9
ページ:
2205-2208
発行年:
2020年
JST資料番号:
W1621A
ISSN:
1538-7933
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)